Shinko Asset Management Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Shinko Asset Management Company’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$72K	Hold	590	–	–	﹤0.01%	460
2016 Q2	$69K	Hold	590	–	–	﹤0.01%	461
2016 Q1	$82K	Sell	590 -40	-6%	-$5.87K	﹤0.01%	431
2015 Q4	$120K	Hold	630	–	–	﹤0.01%	389
2015 Q3	$99K	Buy	630 +40	+7%	+$7.3K	﹤0.01%	407
2015 Q2	$107K	Sell	590 -26	-4%	-$4.49K	﹤0.01%	329
2015 Q1	$107K	Sell	616 -111	-15%	-$20.1K	﹤0.01%	266
2014 Q4	$135K	Sell	727 -100	-12%	-$18.5K	﹤0.01%	253
2014 Q3	$137K	Hold	827	–	–	﹤0.01%	265
2014 Q2	$129K	Hold	827	–	–	﹤0.01%	284
2014 Q1	$126K	Sell	827 -73	-8%	-$11.6K	﹤0.01%	277
2013 Q4	$120K	Hold	900	–	–	﹤0.01%	287
2013 Q3	$105K	Sell	900 -100	-10%	-$11K	﹤0.01%	303
2013 Q2	$92K	Buy	+1,000	New	+$96.4K	﹤0.01%	323

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Shinko Asset Management Company's ALXN Position: Q3 2016 in Review

Shinko Asset Management Company held its Alexion Pharmaceuticals (ALXN) position steady in Q3 2016 at 590 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Shinko Asset Management Company first reported a position in ALXN in Q2 2013 and has held it in 14 quarters since. The position peaked at $137K in Q3 2014. 518 funds tracked by Wall St. Rank hold ALXN as of Q3 2016.

Shinko Asset Management Company held 590 shares of Alexion Pharmaceuticals worth $72K as of Q3 2016.
Shinko Asset Management Company left its Alexion Pharmaceuticals share count unchanged in Q3 2016.
Alexion Pharmaceuticals made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #460 holding.
Shinko Asset Management Company first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
Shinko Asset Management Company's Alexion Pharmaceuticals position peaked at $137K in Q3 2014.
518 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.